statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SAN DIEGO and TAICANG, China, March 19, 2024 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ( Connect Biopharma or the Company ), a global clinical-stage biopharmaceutical...

Connect Biopharma to Participate in H.C. Wainwright 2  Annual Autoimmune & Inflammatory Disease Virtual Conference

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Connect Biopharma Holdings (CNTB Research Report), Aethlon Medical...

Analysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (CNTB), Aethlon Medical (AEMD) and Aclaris Therapeutics (ACRS)

Acciones al alza
Fresh2 Group (NASDAQ:FRES) se anotaron un alza del 28,39% para establecerse en los 0,62 d lares durante la sesi n del after-market del martes.
Connect Biopharma Hldgs (NASDAQ:CNTB...

12 acciones de salud en movimiento en la subasta de cierre del 13/02/2024

James Huang brings over 30 years of biotech experience as a successful entrepreneur, investor and key opinion leader in the healthcare sector SAN DIEGO, CA and TAICANG, China, Feb. 12, 2024 (GLOBE...

Connect Biopharma Appoints Industry Veteran James Huang to Board of Directors

Connect Biopharma Holdings Ltd. engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. Its lead product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha, or IL-4Ra, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma. The company was founded by Zheng Wei and Wu Bin Pan on November 23, 2015 and is headquartered in Taicang, China.

Connect Biopharma Holdings Ltd - ADR

Volume	58,596.00
52-Wk High	$2.84
52-Wk Low	$0.5347

CNTB Connect Biopharma Holdings Ltd - ADR

About

Feed

News

Sentiment

Fundamentals

Sentiment

Message Volume

Community